Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
499,471,363
-
Share change
-
+330,998,262
-
Total reported value
-
$34,544,641,771
-
Put/Call ratio
-
91%
-
Price per share
-
$69.11
-
Number of holders
-
1,008
-
Value change
-
+$22,700,986,606
-
Number of buys
-
958
-
Number of sells
-
111
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2020
As of 30 Jun 2020 Edwards Lifesciences Corp - Common Stock (EW) had 1,008 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 499,471,363 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Bank of New York Mellon Corp, Capital International Investors, ALLIANCEBERNSTEIN L.P., SANDS CAPITAL MANAGEMENT, LLC, FMR LLC, and BROWN ADVISORY INC.
This table shows 1,019 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.